Yu Zhao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Tissue Engineering

Endoplasmic Reticulum

Top Venues

The Journal of organic chemistry

Chemical biology & drug design

Natural product reports

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Shihao Cheng, Chenhu Dong, Yujie Ma, Xiaoyu Xu, Yu Zhao
Skeletal Transformations of Terpenoid Forskolin Employing an Oxidative Rearrangement Strategy. The Journal of organic chemistry 89 (8) (2024)
Shihao Cheng, Chenhu Dong, Yujie Ma, Xiaoyu Xu, Yu Zhao
Skeletal Transformations of Terpenoid Forskolin Employing an Oxidative Rearrangement Strategy. The Journal of organic chemistry (2024)
Ruihan Zhao, Xiao Ni, Chenhu Dong, Jun Xu, Yu Zhao
Synthesis and Preliminary Anticancer Evaluation of 4-C Derivatives of Diphyllin. Chemical biology & drug design 104 (3) (2024)
Shihao Cheng, Chenhu Dong, Yujie Ma, Xiaoyu Xu, Yu Zhao
Skeletal Transformations of Terpenoid Forskolin Employing an Oxidative Rearrangement Strategy. The Journal of organic chemistry 89 (8) (2024)
Yu Li, Shihao Cheng, Yun Tian, Yanan Zhang, Yu Zhao
Recent ring distortion reactions for diversifying complex natural products. Natural product reports 39 (10) (2022)
Rui Cai, Yu Li, Li Zhu, Caiyan Wei, Xiaofeng Bao, Yu Zhao
2, 4, 5-Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity. Chemical biology & drug design 100 (2) (2022)
Qingyun Gu, Xin Wang, Xinyi Liu, Guixia Wu, Yushan Xie, Yu Shao, Yu Zhao, Xiaobao Zeng
Electrochemical sulfonylation of enamides with sodium sulfinates to access β-amidovinyl sulfones. Organic & biomolecular chemistry 19 (38) (2021)
Li Zhu, Rui-Han Zhao, Yu Li, Gong-Qing Liu, Yu Zhao
CtD strategy to construct stereochemically complex and structurally diverse compounds from griseofulvin. Chemical communications (Cambridge, England) 57 (82) (2021)
Li Zhu, Yapeng Lu, Yu Li, Yong Ling, Yu Zhao
Synthesis and evaluation of diphyllin β-hydroxyl amino derivatives as novel V-ATPase inhibitors. Chemical biology & drug design 98 (4) (2021)